top of page

Search Results

Results found for "terry kenakin"

  • Inside Out: Mapping GPCRs from Membrane Codes to Market Moves

    Terry Kenakin, these five modules reveal how location bias, intracellular signaling, and ligand kinetics

  • Why Kinetics Matter More Than Kd in GPCR Drug Discovery

    That’s exactly what Terry’s Corner  delivers this week: real-world kinetic frameworks to help you move Terry Kenakin’s latest lecture in Terry’s Corner  delivers exactly what your discovery teams need now Premium Members get 50%+ discount when they join Terry’s Corner. 🔒 Available only in Terry’s Corner Kenakin is a masterful teacher and communicator—and a leading expert in our field.” — Dr. Terry Kenakin’s featured talk on “The Kinetics of Allostery” offers a rare live glimpse into advanced

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    Terry Kenakin's insights on target residence time can reshape how you evaluate and advance lead compounds Terry's Corner - Unlock the Power of Target Residence Time in Your GPCR Drug Discovery Pipeline Gain Terry Kenakin’s latest insights delve into target residence time, revealing why kinetic persistence often ➡️  Premium Members get 50%+ discount when they join Terry’s Corner.

  • From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry

    Explore the   GPCR University  or enroll in Terry's Corner for GPCR Courses led by Dr. Terry Kenakin. ________ Keyword Cloud: #GPCRresearch #DrugDiscovery #ComputationalChemistry #MolecularModeling

  • Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls

    Terry Kenakin’s session examines not just how  binding works, but why  so many datasets mislead even Kenakin stresses, the apparent simplicity collapses once biological reality intrudes. Kenakin is unequivocal: do not use them. Kenakin outlines a pragmatic checklist for producing reliable orthosteric binding measurements: Cell Terry Kenakin give scientists an uncommon advantage: the ability to interrogate foundational assumptions

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    That’s exactly what Terry’s Corner delivers every week: practical tools from Dr. Terry Kenakin to elevate your science and sharpen your decisions. Terry Kenakin delivers a game-changing framework for teams grappling with the gap between in vitro potency To stay in the know on upcoming courses and AMA session, get the complementary Kenakin Brief , the weekly Kenakin) teaming up with the best GPCR community platform to help train and inspire the next generation

  • Breaking the Myth of High and Low Affinity Sites

    Kenakin’s Emerging Drug Hunter  lecture delivers exclusive, cutting-edge insights that help you move But as Terry Kenakin reveals, this interpretation can be misleading, and sticking with it could slow Kenakin challenges this assumption and shows that what you’re seeing may reflect something entirely different Unlock “Rethinking Affinity” Now Only in Terry's Corner _____ #GPCR #BindingAffinity #Pharmacology

  • Understanding Orthosteric Binding: The Key to Drug Action

    Join Terry Kenakin as he pulls back the curtain on the deceptively simple process of orthosteric binding—the Key Concepts in Binding Terry unpacks several key concepts related to orthosteric binding: Langmuir Adsorption

  • Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024

    Terry Kenakin  and Sam Hoare ! Terry Kenakin to gain insights and prepare for upcoming courses. Kenakin's upcoming courses. Our goal is to ensure that education is within reach for everyone!

  • Target Residence Time: The Hidden Driver of In Vivo Efficacy

    Kenakin’s latest lecture delivers a paradigm shift for pharmacologists working on drugs where in vitro From restricted tissue diffusion to PK–PD dissociation, Kenakin equips you with the kinetic models and Kenakin walks through cases where two equipotent ligands produce radically different clinical outcomes Kenakin offers not just theory, but tools to model, predict, and validate this behavior early. Terry Kenakin Monthly Ask‑Me‑Anything sessions with live Q&A An expanding on‑demand library for novices

  • Dr. GPCR University registration is now open! Secure your spot now!

    Terry Kenakin! Terry Kenakin Reading Materials Access to the private group Certificate Explore: Key metrics for assessing

  • Why “Displacement” Misleads You: Allosteric Binding Demystified

    Kenakin’s latest lecture delivers a wake-up call for pharmacologists interpreting allosteric binding Kenakin shows how even small cooperativity values (like α = 0.1) cap the shift in signal . Kenakin lays out why this is flawed. Binding assays  report on one set of receptor states. Kenakin doesn’t just challenge assumptions. He gives you the tools to replace them . Terry Kenakin An always-growing library of on-demand pharmacology insights The ability to vote on or

  • Why Intracellular Drugs May Hold the Key to GPCR Therapeutics

    Kenakin’s latest lecture delivers a game-changing framework for teams grappling with the gap between Kenakin walks you through the science, the data, and the practical methods for making it happen.   Kenakin shows how this plays out in model systems and clinical data—and why residence time should be Unlock “Intracellular Drugs” Now Only in Terry’s Corner   Why Terry’s Corner In a world where GPCR science Terry Kenakin Monthly Ask‑Me‑Anything sessions with live Q&A An expanding on‑demand library of past lessons

  • GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery

    Kenakin’s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors As Kenakin explains, all GPCR signaling is allosteric , and pretending otherwise introduces risk at every Assay timing and readout design Misclassification of lead candidates Underestimation of in vivo potency Kenakin In this lecture, Kenakin lays out why no ligand binds without altering receptor conformation , and how Terry Kenakin Monthly Ask-Me-Anything sessions A growing, curated on-demand library Opportunities to

  • From Switches to Microcircuits: GPCR Biased Signaling and the Future of Drug Discovery

    Terry Kenakin, read the complete article on the Eurofins DiscoverX page: GPCR Drug Discovery and Development Insights with Terry Kenakin .

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Terry Kenakin  and Sam Hoare ! Registration Closes Tomorrow! Terry Kenakin to acquire valuable insights and prepare for the upcoming courses. Kenakin's upcoming courses. Our goal is to ensure that education is within reach for everyone!

  • Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024

    Terry Kenakin and Sam Hoare ! Terry Kenakin as he shares insights into what you can anticipate for the upcoming courses. Kenakin's upcoming courses. Our goal is to ensure that education is within reach for everyone!

  • Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today

    Kenakin argues, every downstream variable becomes distorted —from preclinical modeling to dose selection Kenakin challenges the assumption that “good enough” tools guarantee progress, emphasizing that judgment Kenakin presents cases where unexpected distribution profiles forced complete strategic pivots Plasma Why Terry’s Corner Terry’s Corner  delivers weekly pharmacology lectures from Dr. Terry Kenakin, monthly AMAs, and a growing on-demand library built around pharmacology's most important

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    Potency does not,” says Kenakin. You must bridge that gap,” Kenakin notes. October 30 AMA Why Terry’s Corner Terry’s Corner  is a living, growing knowledge hub led by Terry Kenakin—a Kenakin with your own enzyme or GPCR interaction puzzles. Subscribe to The Kenakin Brief  today ➤

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    That’s precisely why Terry’s Corner delivers this week: practical, statistical tools that let you move Terry Kenakin walks you through which statistical tests actually answer the question you think you’re Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. Kenakin  happens this month—exclusively inside Terry’s Corner. Bring the curve you’re debating. Unlock Terry’s Corner ➤ Dr. GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr.

  • Irreversible Drugs, Real Control: Design for Durable Target Engagement

    Kenakin from Terry's Corner shows how to tame irreversible drugs so their kinetic power works for you Kenakin — October 30, 12 PM EST   Join Dr. Kenakin live and bring the questions that keep you thinking. Kenakin Trusted insights from biotech, pharma, and academia 🎬 Plus New: Lesson Trailers   Curious about Kenakin… sorely needed in the field." — DrGPCR University Attendee 🚀 Join now — and learn to design

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    But Terry Kenakin’s new Emerging Drug Hunter lecture reveals why this assumption can mislead even experienced Wasted optimization efforts Focus on leads that fail later in development In this exclusive session, Kenakin ’s Corner - Premium Members get an exclusive discount Secure Your Access To Terry's Corner ➤ Why the Kenakin shows exactly how to separate what matters from what misleads—practical, real-world expertise Kenakin. I wish Dr.

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    Terry Kenakin and Sam Hoare ! Terry Kenakin on what to anticipate for these courses! Kenakin's upcoming classes. We’re committed to making education accessible to all!

  • Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery

    The key question Terry raises: If natural scaffolds provided our starting pharmacology, what new scaffolds Kenakin highlights how hybrid molecules  — combining two pharmacophores into one scaffold — enable dual-modality Why Terry’s Corner Terry’s Corner is a continuously growing knowledge platform built for scientists Terry Kenakin, monthly AMA discussions, and on-demand access to a library of expert GPCR teaching sessions to understand. 40 years of expertise at your fingertips: Explore the full library ➤ Subscribe to the Kenakin

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    Terry Kenakin to elevate your science and sharpen your calls. Kenakin is today, September 18th, 12-1 pm EST in Terry’s Corner. Corner members get to rewatch the recording Subscribe to the Kenakin Brief and Join the Live AMA ➤ Celtarys Kenakin is a leading expert in the field. Kenakin is a masterful teacher and communicator." — DrGPCR University Attendee Everything you need to

  • Quantifying Receptor Selectivity in Modern Drug Discovery

    Kenakin demonstrates in this session of Terry’s Corner, what we often measure is not receptor selectivity Kenakin reveals how two compounds tested in different systems can appear to differ by thousands-fold Kenakin uses a lever analogy where: Efficacy is the weight applied. Kenakin outlines a practical solution: use a potency metric that incorporates both efficacy and EC₅₀ Terry Kenakin, monthly live AMAs, and a growing on-demand library built for scientists who need clarity

  • GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026

    In this Terry’s Corner lesson, Dr. Terry Kenakin reframes GPCR binding affinity experiments  as context-dependent measurements , not fixed Already available in Terry’s Corner: 30 in-depth lessons and 3 live AMAs  spanning binding, kinetics, Premium Membership pricing increases in 2026, and the 67% Terry’s Corner discount is going away. . 👉   Join Terry's Corner Before Dec 31st, 2025 🎧 Dr.

  • Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs

    Premium Members also receive a 50%+ discount on Terry’s Corner — unlocking advanced pharmacology depth Terry Kenakin (for a limited time).

  • Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines

    Kenakin used those questions to explore how pharmacological reasoning turns experimental signals into Kenakin explains, pharmacology differs from other life sciences precisely because it builds quantitative Kenakin often recalls advice from Nobel laureate James Black: Chemists make the drugs. Terry’s Corner  was created to close that gap. Terry Kenakin Monthly live AMAs with real discovery questions A growing on-demand library of practical

bottom of page